ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.
Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.
Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.
Bush Appoints Seven to NCAB, Designates Runowicz as Chairman.
IOM Report Recommends Solutions to Problem of Medication Errors.
Jury Finds USC Geneticist William French Anderson Guilty of Sexual Abuse of a Child.
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds
- A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m. - Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
- A new diagnostic lens—and a lasting scientific legacy
- OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill









